Cerebral Oximetry in Newborns - Comparing INVOS 5100c and OxyPrem vs. 1.2
1 other identifier
observational
24
1 country
1
Brief Summary
Regional tissue oxygenation (cStO2) can be monitored by near infrared spectroscopy. The commercial device INVOS 5100 (COVIDIEN, Mansfield, MA, USA) and the prototype OxyPrem vs. 1.2 (Biomedical Optics Research Laboratory, Zurich, Switzerland) will be used simultaneously to test for their relative sensitivity for low oxygen levels just after birth on term infants born by elective caesarean section. Reproducibility will be examined by replacements of the sensors six times the next day when the infant is stable and quiet. The Adult Somasensor (INVOS) will be used together with the OxyPrem sensor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 16, 2013
CompletedFirst Posted
Study publicly available on registry
January 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedOctober 7, 2013
September 1, 2013
6 months
January 16, 2013
September 30, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cerebral oxygenation
The sensors of both instruments will be placed on each side of the head. They will be held by hand by self-adhesive tape as appropriate.
10 minutes
Secondary Outcomes (1)
Reproducibility
10 minutes
Study Arms (1)
Near-infrared spectroscopy sensors
Term infants born by elective Caesarean section
Eligibility Criteria
Healthy term infants born by elective caesarean section at Rigshospitalet, Denmark
You may qualify if:
- Term infants
- Elective caesarean section
You may not qualify if:
- Thick hair that makes good measurements difficult/impossible
- obvious malformations or syndromes
- Complications in relation to caesarean section
- Depression after birth (APGAR \< 8 after 1 minute)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rigshospitalet, Denmarklead
- The Augustinus Foundation, Denmark.collaborator
Study Sites (1)
Gorm Greisen
Copenhagen, Copenhagen, 2100, Denmark
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
January 16, 2013
First Posted
January 18, 2013
Study Start
January 1, 2013
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
October 7, 2013
Record last verified: 2013-09